Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan.

SN Comprehensive Clinical Medicine
Zia Ul MustafaSyed Shahzad Hasan

Abstract

The discovery of different antimicrobial agents has revolutionized the treatment against a variety of infections for many decades, but the emergence of antimicrobial resistance require rigorous measures, even amid the coronavirus disease 2019 (COVID-19) pandemic. This retrospective study aimed to examine the consumption of antibiotics in patients with COVID-19 admitted into the five hospitals in the province of Punjab, Pakistan. We collected data on the consumption of antibiotics, classified using the World Health Organization (WHO) AWaRe (Access, Watch, and Reserve), within two months-August and September, 2020, and the corresponding months in 2019. Consumption of antibiotics was presented as daily define dose (DDD) per 100 occupied bed-days. Eight different classes of antibiotics were prescribed to patients with COVID-19 without culture tests being performed, with the prescribing of antibiotics of the Watch category was especially prevalent. The consumption of antibiotics was higher during the COVID-19 pandemic compared to the pre-pandemic period: the consumption of azithromycin increased from 11.5 DDDs per 100 occupied bed-days in 2019 to 17.0 DDDs per 100 occupied bed-days in 2020, while the consumption of ceftriaxone incre...Continue Reading

References

Jul 20, 2007·Journal of Clinical Pharmacy and Therapeutics·K UrbánekL Santavá
Feb 23, 2020·The Lancet Infectious Diseases·Ensheng DongLauren Gardner
Mar 29, 2020·Science·Kai Kupferschmidt, Jon Cohen
Apr 4, 2020·American Journal of Respiratory and Critical Care Medicine·Yingzhen DuGuogang Xu
May 3, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy M RawsonAlison Holmes
Jul 24, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Matthew J NestlerMichael P Stevens
Aug 4, 2020·Bulletin of the World Health Organization·Haileyesus GetahunHanan H Balkhy
Aug 21, 2020·Clinical Drug Investigation·Chia Siang Kow, Syed Shahzad Hasan
Aug 30, 2020·International Journal of Antimicrobial Agents·Yixin LiewShimin Jasmine Chung
Oct 3, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Chia Siang Kow, Syed Shahzad Hasan
Oct 4, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Elske SieswerdaW Joost Wiersinga
Nov 30, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Bruno Gonzalez-Zorn
Jan 28, 2021·International Journal of Environmental Research and Public Health·Enrico BentivegnaPaolo Martelletti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia
Roberto ColladoMontserrat Pérez
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Anna Murgadella-SanchoIsabel Oriol-Bermúdez
© 2021 Meta ULC. All rights reserved